Related Experiment Video
Updated: Jul 12, 2026

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
PAPP-A: a possible pathogenic link to the instability of atherosclerotic plaque
Xuping Li1, Qiming Liu, Tao Zhou
1Department of Cardiology, Second Xiangya Hospital, Central South University, Renming Road 359, Changsha, China.
Insights
Pregnancy associated plasma protein A (PAPP-A) may cause atherosclerotic plaque instability, a key factor in acute coronary syndromes (ACS). Targeting PAPP-A could offer a new treatment strategy for ACS patients.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Pathology
Background:
- Acute coronary syndromes (ACS) are primarily caused by the rupture of coronary atherosclerotic plaques and subsequent thrombus formation.
- Elevated serum concentrations of Pregnancy associated plasma protein A (PAPP-A) are linked to ACS, indicating plaque instability and poor prognosis.
- The high expression of PAPP-A in unstable plaques remains a puzzling observation.
Purpose of the Study:
- To investigate the hypothesis that PAPP-A contributes to atherosclerotic plaque instability, playing a role in ACS pathogenesis.
- To explore PAPP-A as a potential therapeutic target for ACS.
Main Methods:
- Review of existing studies examining PAPP-A expression in different types of atherosclerotic plaques (eroded, ruptured, stable).
- Analysis of PAPP-A levels in patients with varying carotid plaque echogenicity (hyperechoic, isoechoic, hypoechoic).
Main Results:
- PAPP-A is abundantly expressed in eroded and ruptured plaques, but minimally in stable plaques.
- Higher PAPP-A levels are observed in patients with hyperechoic or isoechoic carotid plaques compared to those with hypoechoic lesions.
Conclusions:
- PAPP-A expression correlates with atherosclerotic plaque instability.
- PAPP-A may be a causative factor in plaque instability and ACS.
- PAPP-A monoclonal antibodies represent a potential novel therapeutic approach for treating ACS.
Abstract:
The rupture of coronary atherosclerotic plaque and subsequent thrombus formation are major events underlying acute coronary syndromes (ACS). Pregnancy associated plasma protein A (PAPP-A) is a member of the metzincin superfamily of metalloproteinases originally identified in the serum of pregnant women. Recent studies indicate that ACS is associated with elevated serum concentrations of PAPP-A. PAPP-A level is not only a marker of plaque instability favoring the progression to myocardial infarction, but is indicative of a poor prognosis even after the occurrence of an acute ischemic event caused by plaque instability. Why PAPP-A expression in unstable plaques is high is a puzzling problem. We hypothesized that PAPP-A is a possible cause of the instability of atherosclerotic plaque which plays a role in ACS. Studies found that PAPP-A was abundantly expressed in both eroded and ruptured plaques, but was only minimally expressed in stable plaques. Other studies have also demonstrated that patients with hyperechoic or isoechoic carotid plaques exhibit significantly higher PAPP-A levels than those with hypoechoic early carotid lesions. If the hypothesis is confirmed, administration of PAPP-A monoclonal antibodies may be used to eliminate the pathogen. It will be a new target point to treat ACS.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Inflammation
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
